These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12920022)

  • 41. TGF-betas and TGF-beta receptors in atherosclerosis.
    McCaffrey TA
    Cytokine Growth Factor Rev; 2000; 11(1-2):103-14. PubMed ID: 10708958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development and function of murine RORγt+ iNKT cells are under TGF-β signaling control.
    Havenar-Daughton C; Li S; Benlagha K; Marie JC
    Blood; 2012 Apr; 119(15):3486-94. PubMed ID: 22371886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma.
    Laouar Y; Sutterwala FS; Gorelik L; Flavell RA
    Nat Immunol; 2005 Jun; 6(6):600-7. PubMed ID: 15852008
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
    Bierie B; Stover DG; Abel TW; Chytil A; Gorska AE; Aakre M; Forrester E; Yang L; Wagner KU; Moses HL
    Cancer Res; 2008 Mar; 68(6):1809-19. PubMed ID: 18339861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies.
    Hall FL; Benya PD; Padilla SR; Carbonaro-Hall D; Williams R; Buckley S; Warburton D
    Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):303-10. PubMed ID: 8645222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pioglitazone inhibits connective tissue growth factor expression in advanced atherosclerotic plaques in low-density lipoprotein receptor-deficient mice.
    Game BA; He L; Jarido V; Nareika A; Jaffa AA; Lopes-Virella MF; Huang Y
    Atherosclerosis; 2007 May; 192(1):85-91. PubMed ID: 16901490
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suppression of tumor metastasis by blockade of transforming growth factor beta signaling in bone marrow cells through a retroviral-mediated gene therapy in mice.
    Shah AH; Tabayoyong WB; Kundu SD; Kim SJ; Van Parijs L; Liu VC; Kwon E; Greenberg NM; Lee C
    Cancer Res; 2002 Dec; 62(24):7135-8. PubMed ID: 12499244
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance.
    McCaffrey TA; Du B; Fu C; Bray PJ; Sanborn TA; Deutsch E; Tarazona N; Shaknovitch A; Newman G; Patterson C; Bush HL
    J Mol Cell Cardiol; 1999 Sep; 31(9):1627-42. PubMed ID: 10471347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transforming growth factor-beta inhibits human antigen-specific CD4+ T cell proliferation without modulating the cytokine response.
    Tiemessen MM; Kunzmann S; Schmidt-Weber CB; Garssen J; Bruijnzeel-Koomen CA; Knol EF; van Hoffen E
    Int Immunol; 2003 Dec; 15(12):1495-504. PubMed ID: 14645158
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aberrant transforming growth factor-beta signaling in azoxymethane-induced mouse colon tumors.
    Guda K; Giardina C; Nambiar P; Cui H; Rosenberg DW
    Mol Carcinog; 2001 Aug; 31(4):204-13. PubMed ID: 11536370
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of gamma-irradiation and bone marrow transplantation on atherosclerosis in LDL receptor-deficient mice.
    Schiller NK; Kubo N; Boisvert WA; Curtiss LK
    Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1674-80. PubMed ID: 11597944
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice.
    Potteaux S; Combadière C; Esposito B; Lecureuil C; Ait-Oufella H; Merval R; Ardouin P; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1858-63. PubMed ID: 16763157
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development.
    Van Eck M; Bos IS; Hildebrand RB; Van Rij BT; Van Berkel TJ
    Am J Pathol; 2004 Sep; 165(3):785-94. PubMed ID: 15331403
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury.
    Kobayashi K; Yokote K; Fujimoto M; Yamashita K; Sakamoto A; Kitahara M; Kawamura H; Maezawa Y; Asaumi S; Tokuhisa T; Mori S; Saito Y
    Circ Res; 2005 Apr; 96(8):904-12. PubMed ID: 15790953
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concerted action of TGF-beta 1 and its type II receptor in control of epidermal homeostasis in transgenic mice.
    Cui W; Fowlis DJ; Cousins FM; Duffie E; Bryson S; Balmain A; Akhurst RJ
    Genes Dev; 1995 Apr; 9(8):945-55. PubMed ID: 7774812
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hematopoietic arginase 1 deficiency results in decreased leukocytosis and increased foam cell formation but does not affect atherosclerosis.
    Ren B; Van Kampen E; Van Berkel TJ; Cruickshank SM; Van Eck M
    Atherosclerosis; 2017 Jan; 256():35-46. PubMed ID: 27998825
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms.
    Morris SM; Davison J; Carter KT; O'Leary RM; Trobridge P; Knoblaugh SE; Myeroff LL; Markowitz SD; Brett BT; Scheetz TE; Dupuy AJ; Starr TK; Grady WM
    Int J Cancer; 2017 Feb; 140(4):853-863. PubMed ID: 27790711
    [TBL] [Abstract][Full Text] [Related]  

  • 58. On the mechanisms by which transforming growth factor-beta 2 alters antigen-presenting abilities of macrophages on T cell activation.
    Takeuchi M; Kosiewicz MM; Alard P; Streilein JW
    Eur J Immunol; 1997 Jul; 27(7):1648-56. PubMed ID: 9247573
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transforming growth factor-β signaling in myogenic cells regulates vascular morphogenesis, differentiation, and matrix synthesis.
    Jaffe M; Sesti C; Washington IM; Du L; Dronadula N; Chin MT; Stolz DB; Davis EC; Dichek DA
    Arterioscler Thromb Vasc Biol; 2012 Jan; 32(1):e1-11. PubMed ID: 21979435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.
    Wei H; Hu JH; Angelov SN; Fox K; Yan J; Enstrom R; Smith A; Dichek DA
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28119285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.